Version 1
: Received: 17 June 2021 / Approved: 24 June 2021 / Online: 24 June 2021 (10:22:51 CEST)
Version 2
: Received: 24 July 2021 / Approved: 28 July 2021 / Online: 28 July 2021 (16:56:31 CEST)
Hwang, D. Y.; Kim, S. W.; Jung, J. Y.; Kim, R. Clinical Experience with the Fifth-Generation of a Breast Implant with a Smooth, Fine Surface from a Korean Manufacturer in Asian Women. Journal of Biosciences and Medicines, 2022, 10, 132–144. https://doi.org/10.4236/jbm.2022.106012.
Hwang, D. Y.; Kim, S. W.; Jung, J. Y.; Kim, R. Clinical Experience with the Fifth-Generation of a Breast Implant with a Smooth, Fine Surface from a Korean Manufacturer in Asian Women. Journal of Biosciences and Medicines, 2022, 10, 132–144. https://doi.org/10.4236/jbm.2022.106012.
Hwang, D. Y.; Kim, S. W.; Jung, J. Y.; Kim, R. Clinical Experience with the Fifth-Generation of a Breast Implant with a Smooth, Fine Surface from a Korean Manufacturer in Asian Women. Journal of Biosciences and Medicines, 2022, 10, 132–144. https://doi.org/10.4236/jbm.2022.106012.
Hwang, D. Y.; Kim, S. W.; Jung, J. Y.; Kim, R. Clinical Experience with the Fifth-Generation of a Breast Implant with a Smooth, Fine Surface from a Korean Manufacturer in Asian Women. Journal of Biosciences and Medicines, 2022, 10, 132–144. https://doi.org/10.4236/jbm.2022.106012.
Abstract
Background In this study, we describe our clinical experience with the fifth-generation of a breast implant with a smooth, fine surface from a Korean manufacturer (BellaGelÒ SmoothFine; HansBiomed Co. Ltd., Seoul, Korea) in Asian women. Methods We analyzed 223 women (mean age=35.28±9.45 years and mean follow-up period=12.03±2.48 months), comprising 118 bilateral cases and 109 unilateral ones, who received breast augmentation using the BellaGelÒ SmoothFine at our hospital between June 4, 2018 and February 28, 2019. For safety assessment, we analyzed frequencies of postoperative complications and overall survival of the BellaGelÒ SmoothFine. Results Postoperatively, complications (12 cases, 5.38%) include asymmetry (3 cases, 1.35%), hematoma (2 cases, 0.90%), hypertrophic scars (2 cases, 0.90%), wound disruption (2 cases, 0.90%), rippling (1 case, 0.45%), capsular contracture (1 case, 0.45%), stretch deformities with skin excess (1 case, 0.45%). In addition, time-to-events were calculated as 10.94±0.64 months (95% CI 9.69-12.19) and the survival rate reached 0.290±0.168 (95% CI 0.094-0.901) at 12 months postoperatively. Conclusions Here, we describe our clinical experience with the BellaGelÒ SmoothFine. Our results are of significance in that this is the first report about the fifth-generation of a breast implant with a smooth, fine surface from a Korean manufacturer in Asian women.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Commenter: Robert Kim
Commenter's Conflict of Interests: Author